bFGF-Loaded Mesoporous Silica Nanoparticles Promote Bone Regeneration Through the Wnt/β-Catenin Signalling Pathway
Mingkui Shen,Lulu Wang,Li Feng,Yi Gao,Sijing Li,Yulan Wu,Chuangye Xu,Guoxian Pei
DOI: https://doi.org/10.2147/IJN.S366926
IF: 7.033
2022-06-08
International Journal of Nanomedicine
Abstract:Mingkui Shen, &ast Lulu Wang, &ast Li Feng, Yi Gao, Sijing Li, Yulan Wu, Chuangye Xu, Guoxian Pei School of Medicine, Southern University of Science and Technology, Shenzhen, 518055, People's Republic of China &astThese authors contributed equally to this work Correspondence: Chuangye Xu; Guoxian Pei, Email ; Background: Bone defects remain an unsolved clinical problem due to the lack of effective osteogenic induction protocols. Nanomaterials play an important role in bone defect repair by stimulating osteogenesis. However, constructing an effective bioactive nanomaterial remains a substantial challenge. Methods: In this study, mesoporous silica nanoparticles (MSNs) were prepared and used as nanocarriers for basic fibroblast growth factor (bFGF). The characteristics and biological properties of the synthetic were tested. The osteogenic effects of the particles on the behavior of MC3T3-E1 cells were investigated in vitro. In addition, the differentially expressed genes during induction of osteogenesis were analyzed by transcriptomic sequencing. Radiological and histological observations were carried out to determine bone regeneration capability in a distal femur defect model. Results: Achieving bFGF sustained release, had uniform spherical morphology and good biocompatibility. In vitro osteogenesis induction experiments showed that exhibited excellent osteogenesis performance, with upregulation of osteogenesis-related genes (RUNX2, OCN, Osterix, ALP). Transcriptomic sequencing revealed that the Wnt/β-catenin signalling pathway could be activated in regulation of biological processes. In vivo, bone defect repair experiments showed enhanced bone regeneration, as indicated by radiological and histological analysis, after the application of Conclusion: can promote bone regeneration by activating the Wnt/β-catenin signalling pathway. These particles are expected to become a potential therapeutic bioactive material for clinical application in repairing bone defects in the future. Keywords: mesoporous silica, basic fibroblast growth factor, osteogenesis, transcriptomics sequencing, Wnt/β-catenin signalling pathway, bone regeneration Clinical bone defects frequently result from congenital disorders, trauma, bone tumors, and osteomyelitis, etc, 1–3 afflicting the physical and mental health of patients. Current clinical strategies typically use autografts, allografts, xenografts and inorganic grafts at the bone defects site for tissue repair and bone regeneration. 4,5 However, these approaches have limitations, such as limited donor mass, poor osteoinductivity, infection, host immunoreaction and unsatisfactory biological activity, limiting their practical application. 2,5,6 In addition, many previous studies have demonstrated that the direct injection of bioactive agents (IGF, TGF-β, and BMP) into the defect site may lead to uncontrolled release of drugs or factors. 7 Therefore, clinical healing of bone defects remains a major challenge for surgeons, and synthetic biomaterials with the ability to stimulate osteogenesis for promoting bone healing have become the focus of research. To overcome the above challenges, the combination of nanomaterials with various bioactive agents may be a promising approach for bone defect repair. Because of their high specific surface area, good biocompatibility and biodegradability, mesoporous materials have been widely studied in basic research and real-world applications, 8 and mesoporous silica has attracted increasing attention in the biomedical field. As a typical nanocarrier, MSNs are widely used for the loading of drugs and biological macromolecules such as RNA and peptides, and they achieve sustained and controlled release of bioactive factors. Si ions released during the degradation of MSNs can upregulate the expression of osteogenesis-related genes (OCN, RUNX2 and OPN) in osteoblasts to promote bone repair. 9 The mesoporous structure of MSNs contributes to the deposition of hydroxyapatite (HA) and promotes mineralization and osteogenesis. MSNs can also induce an immune microenvironment conducive to guiding immune-mediated osteogenesis, and macrophage uptake of nanomaterials plays an important role in the formation of this immune microenvironment. 10 However, the biological activity of MSNs is relatively low, and the nanomaterial–cell interaction is weak. Therefore, the combination of drugs or growth factors with MSNs will provide great potential to enhance the bioactivity and osteogenic performance of bone repair materials. Basic fibroblast growth factor (bFGF) is mainly secreted by endothelial cells, smooth muscle cells and macrophages and is a heparin-binding growth factor th -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology